Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome

被引:65
作者
Ong, Madeleine [1 ]
Peng, Jie [1 ,2 ]
Jin, Xingliang [1 ]
Qu, Xianqin [1 ]
机构
[1] Univ Technol Sydney, Sch Life Sci, POB 123, Broadway, NSW 2007, Australia
[2] Suzhou Wuzhong Peoples Hosp, Dept Obstet & Gynaecol, Suzhou, Jiangsu, Peoples R China
来源
AMERICAN JOURNAL OF CHINESE MEDICINE | 2017年 / 45卷 / 03期
关键词
Polycystic Ovary Syndrome; Infertility; Insulin Resistance; Hormone Therapy; Chinese Herbal Medicine; Review; HORMONE-BINDING GLOBULIN; THECA-INTERSTITIAL CELLS; ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; LUTEINIZING-HORMONE; GRANULOSA-CELLS; IN-VITRO; ANDROGEN PRODUCTION; METFORMIN THERAPY; COMMON VARIANTS;
D O I
10.1142/S0192415X17500252
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Polycystic ovary syndrome (PCOS) is a complex heterogeneous disorder characterized by androgen excess and ovulatory dysfunction; it is now known to be closely linked to metabolic syndrome. Recent research suggests that insulin resistance plays an important role in the pathogenesis of PCOS which may lead to the excessive production of androgens by ovarian theca cells. Currently there is no single drug that can treat both the reproductive and metabolic complications of the disorder. Existing pharmaceutical agents such as hormonal therapies have been associated with side effects and are not appropriate for PCOS women with infertility. Additionally, insulin sensitizing agents useful for treating the metabolic abnormalities in PCOS have limited efficacy for treating reproductive aspects of the disorder. Chinese herbal medicines have a long history of treating gynaecological problems and infertility and therefore may be a novel approach to the treatment of PCOS. Current research demonstrates that the compounds isolated from herbs have shown beneficial effects for PCOS and when combined in an herbal formula can target both reproductive and metabolic defects simultaneously. Therefore, further investigation into Chinese herbal medicine in the treatment of PCOS is warranted.
引用
收藏
页码:405 / 422
页数:18
相关论文
共 96 条
  • [1] The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome.
    Al-Azemi M.
    Omu F.E.
    Omu A.E.
    [J]. Archives of Gynecology and Obstetrics, 2004, 270 (4) : 205 - 210
  • [2] Alfred A, 2011, AUST FAM PHYSICIAN, V40, P718
  • [3] Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women
    Angeles Martinez-Garcia, M.
    Gambineri, Alessandra
    Alpanes, Macarena
    Sanchon, Raul
    Pasquali, Renato
    Escobar-Morreale, Hector F.
    [J]. HUMAN REPRODUCTION, 2012, 27 (12) : 3569 - 3576
  • [4] A survey of the use of complementary medicine by a self-selected community group of Australian women with polycystic ovary syndrome
    Arentz, Susan
    Smith, Caroline Anne
    Abbott, Jason Anthony
    Bensoussan, Alan
    [J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
  • [5] Metformin directly inhibits androgen production in human thecal cells
    Attia, GR
    Rainey, WE
    Carr, BR
    [J]. FERTILITY AND STERILITY, 2001, 76 (03) : 517 - 524
  • [6] Ayyad C, 2000, Obes Rev, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x
  • [7] The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
    Azziz, Ricardo
    Carmina, Enrico
    Dewailly, Didier
    Diamanti-Kandarakis, Evanthia
    Escobar-Morreale, Hector F.
    Futterweit, Walter
    Janssen, Onno E.
    Legro, Richard S.
    Norman, Robert J.
    Taylor, Ann E.
    Witchel, Selina F.
    [J]. FERTILITY AND STERILITY, 2009, 91 (02) : 456 - 488
  • [8] Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity
    Baillargeon, JP
    Jakubowicz, DJ
    Iuorno, MJ
    Jakubowicz, S
    Nestler, JE
    [J]. FERTILITY AND STERILITY, 2004, 82 (04) : 893 - 902
  • [9] Barber Thomas M, 2015, Clin Med (Lond), V15 Suppl 6, ps72, DOI [10.7861/clinmedicine.16-3-262, 10.7861/clinmedicine.15-6-s72]
  • [10] Barthelmess Erin K, 2014, Front Biosci (Elite Ed), V6, P104